ArticleScientific reports2026
Mixed-source introductions successfully enhance the genetic diversity of captive forest musk deer (Moschus berezovskii).
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Wild Forest musk deer (FMD) has been declining due to continuing poaching and habitat loss. Although captive breeding has increased population numbers, maintaining genetic diversity in these farmed populations has become increasingly urgent and challenging due to depleted wild stocks and loss of genetic diversity from inbreeding in captive populations. Using samples from 683 individuals, we assessed mitochondrial genetic diversity (ATP8-6, Cytb, control region [CR]), structure, and maternal lineage patterns in a newly established ex-situ population (BB; founded 2019 with 44 breeders) and its three founding source populations (PZH, TZL, GL) in western China. Our results demonstrate that the ex-situ population maintains higher nucleotide diversity (π) in ATP8-6 and Cytb than its source populations, while exhibiting comparable haplotype diversity (Hd). Phylogenetic and haplotype network analyses identified three maternal lineages across populations, with the ex-situ population containing representatives of all lineages and showing significant genetic differentiation from at least some founder groups, indicating the mixed-source introduction strategy successfully created a genetically distinct population. Neutrality tests and mismatch distributions suggested historical bottlenecks in baseline populations, whereas the ex-situ population showed signatures of recent admixture and expansion. These findings highlight the potential benefits of mixed-source introductions in enhancing genetic diversity during ex-situ conservation. We recommend long-term genetic monitoring and in-depth analysis of population history to refine translocation strategies and support the long-term viability of FMD under managed care.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.